Association study of paroxetine therapeutic response with SERT gene polymorphisms in patients with major depressive disorder

We investigated the relationships between LS promoter (SERTPR) and ls intron2 (SERTin2) genetic variants of serotonin transporter (SERT) polymorphisms with treatment response in 130 patients with major depressive disorder (MDD) treated with paroxetine (20 mg/day) for 6 weeks. To assess and evaluate...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The world journal of biological psychiatry 2008, Vol.9 (3), p.190-197
Hauptverfasser:	Bozina, Nada, Mihaljevic Peles, Alma, Sagud, Marina, Bilusic, Hrvoje, Jakovljevic, Miro
Format:	Artikel
Sprache:	eng
Schlagworte:	Depressive Disorder, Major - drug therapy Depressive Disorder, Major - genetics Diagnostic and Statistical Manual of Mental Disorders DNA Primers - genetics Female genetics Humans major depressive disorder Male Middle Aged Minisatellite Repeats - genetics Paroxetine Paroxetine - therapeutic use Polymorphism, Genetic - genetics Serotonin Plasma Membrane Transport Proteins - genetics serotonin transporter Serotonin Uptake Inhibitors - therapeutic use treatment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!